Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia

[Image: see text]Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.

Detalles Bibliográficos
Autores principales: Kuwahara, Ai, Sasaki, Ryu, Fukushima, Masanori, Haraguchi, Masafumi, Miuma, Satoshi, Miyaaki, Hisamitsu, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411641/
https://www.ncbi.nlm.nih.gov/pubmed/32782972
http://dx.doi.org/10.1002/jgh3.12351
_version_ 1783568425411411968
author Kuwahara, Ai
Sasaki, Ryu
Fukushima, Masanori
Haraguchi, Masafumi
Miuma, Satoshi
Miyaaki, Hisamitsu
Nakao, Kazuhiko
author_facet Kuwahara, Ai
Sasaki, Ryu
Fukushima, Masanori
Haraguchi, Masafumi
Miuma, Satoshi
Miyaaki, Hisamitsu
Nakao, Kazuhiko
author_sort Kuwahara, Ai
collection PubMed
description [Image: see text]Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.
format Online
Article
Text
id pubmed-7411641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-74116412020-08-10 Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia Kuwahara, Ai Sasaki, Ryu Fukushima, Masanori Haraguchi, Masafumi Miuma, Satoshi Miyaaki, Hisamitsu Nakao, Kazuhiko JGH Open Brief Reports [Image: see text]Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts. Wiley Publishing Asia Pty Ltd 2020-05-08 /pmc/articles/PMC7411641/ /pubmed/32782972 http://dx.doi.org/10.1002/jgh3.12351 Text en © 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Reports
Kuwahara, Ai
Sasaki, Ryu
Fukushima, Masanori
Haraguchi, Masafumi
Miuma, Satoshi
Miyaaki, Hisamitsu
Nakao, Kazuhiko
Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title_full Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title_fullStr Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title_full_unstemmed Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title_short Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
title_sort shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411641/
https://www.ncbi.nlm.nih.gov/pubmed/32782972
http://dx.doi.org/10.1002/jgh3.12351
work_keys_str_mv AT kuwaharaai shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT sasakiryu shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT fukushimamasanori shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT haraguchimasafumi shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT miumasatoshi shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT miyaakihisamitsu shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia
AT nakaokazuhiko shuntocclusionpriortolenvatinibadministrationpreventshepaticencephalopathyandhyperammonemia

Ejemplares similares